Skip Ribbon Commands
Skip to main content
CIBMTR

Publication List

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   |   Reference Center   |   Publication List
  • Print
  • Share

CIBMTR Publication List

Since 1972, use of CIBMTR data and statistical resources have resulted in more than 1,400 publications. These publications are organized by year below, and can be searched to help you quickly find the information you need. ​


Display:



2020

Year Title Authors Publication
2020 Comprehensive prognostication in critically ill pediatric hematopoietic cell transplant patients: Results from merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Gale RP, Guinan E, Hematti P, Keating AK, Marks DI, Olsson R, Savani BN, Ustun C, Williams KM, Pasquini MC, Dvorak CC Biol Blood Marrow Transplant 26(2):333-342
2020 Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury-laboratory confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant. Dandoy CE, Kim S, Chen M, Ahn K-W, Ardura MI, Brown V, Chhabra S, Diaz MA, Dvorak C, Farhadfar N, Flagg A, Ganguly S, Hale GA, Hashmi SK, Hematti P, Martino R, Nishihori T, Nusrat R, Olsson RF, Rotz SJ, Sung AD, Perales M-A, Lindemans CA, Komanduri KV, Riches ML JAMA Netw Open 3(1):e1918668
2020 Health care reimbursement, service utilization, and financial responsibility among Medicare beneficiaries with multiple myeloma receiving autologous hematopoietic cell transplantation in inpatient and outpatient settings. Dunavin N, Mau L-W, Meyer CL, Divine C, Leppke S, D'Souza A, Denzen E, Saber W, Burns LJ, Ganguly S Biol Blood Marrow Transplant
2020 Cellular immunotherapy for refractory DLBCL in the CART era: still a role for allogeneic transplantation? Dreger P, Fenske TS, Montoto S, Pasquini MC, Sureda A, Hamadani M Biol Blood Marrow Transplant
2020 Randomized Multicenter Trial of Sirolimus vs. Prednisone as Initial Therapy for Standard Risk Acute GVHD: BMT CTN 1501 Pidala J, Hamadani M, Dawson P, Martens M, Alousi A, Jagasia MH, Efebera YA, Chhabra S, Pusic I, Holtan SG, Ferrara JL, Levine JE, Mielcarek M, Anasetti C, Antin J, Bolaños-Meade J, Howard A, Logan BR, Leifer ES, Pritchard TS, Horowitz MM, MacMillan ML Blood 135(2):97-107
2020 Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling. Holstein SA, Al-Kadhimi Z, Costa LJ, Hahn T, Hari P, Hillengass J, Jacob A, Munshi NC, Oliva S, Pasquini MC, Shi Q, Stadtmauer EA, Waldvogel SL, McCarthy PL Biol Blood Marrow Transplant 26(1):e7-e15
2020 Causal inference in randomized clinical trials. Zheng C, Dai R, Gale RP, Zhang M-J Bone Marrow Transplant 55(1):4-8
2020 Statistical analyses of clinical trials in haematopoietic cell transplantation or why there is a strong correlation between people drowning after falling out of a fishing boat and marriage rate in Kentucky. Gale RP, Zhang M-J Bone Marrow Transplant 55(1):1-3
2020 Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: A retrospective cohort study. Petersdorf EW, Carrington M, O'hUigin C, Bengtsson M, De Santis D, Dubois V, Gooley T, Horowitz M, Hsu K, Madrigal JA, Maiers MJ, Malkki M, McKallor C, Morishima Y, Oudshoorn M, Spellman SR, Villard J, Stevenson P Lancet Haematol 7(1):e50-e60
View current and planned studies
Last Updated: 10/21/2019 11:08 AM
CIBMTR